Bevacizumab Plus Capecitabine (Xeloda) in Patients With Untreated Metastatic Colorectal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Arash Naeim, MD, PhD
University of California, Los Angeles
Study Chair - Randy Hecht, MD
University of California, Los Angeles
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Central Hematology Oncology Medical Group, Inc.
Alhambra, California, United States
- Comprehensive Blood and Cancer Center
Bakersfield, California, United States
- Virginia K. Crosson Cancer Center
Fullerton, California, United States
- Pacific Shores Medical Group
Long Beach, California, United States
- Ucla Medical Center
Los Angeles, California, United States
- North Valley Hematology/oncology Medical Group
Northridge, California, United States
- Ventura County Hematology-Oncology Specialists
Oxnard, California, United States
- Wilshire Oncology Medical Group, Inc.
Pomona, California, United States
- Cancer Care Associates Medical Group, Inc.
Redondo Beach, California, United States
- Santa Barbara Hematology Oncology Medical Group, Inc.
Santa Barbara, California, United States
- Central Coast Medical Oncology Corporation
Santa Maria, California, United States
- Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Mar 2006
- Primary completion
- 31 Mar 2011
- Completion
- 31 Mar 2011
- Last update posted
- 6 Feb 2017
- Registered enrollment
- 45
- Registry id
- NCT00203411
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.